PRMT1 can be detected in breast cancer, lung cancer, colon cancer, bladder cancer, and acute myeloid leukemia, but its expression may be disordered in different types of cancer (Cheung et al., 2007; Feng et al., 2013; Goulet et al., 2007; Mathioudaki et al., 2008). Here, PRMT1 is linked to breast carcinoma.